Hesperidin and Bone Health in Postmenopausal Women

Completed · Not applicable

Conditions studied: Osteoporosis, Postmenopausal

In brief

The primary objective of this clinical trial is to test hesperidin with and without CALCILOCK® for bone resorption suppressing effect in postmenopausal women. The secondary objective is the comparison between 41Ca technology and classical biomarker to evaluate bone resorption.

Key facts

Study ID

NCT01881204

Run by

Purdue University

People needed

12

Starts

2011-04-01

Expected to finish

2012-10-01

Last updated by the study team

2018-05-17

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women at least 4 years postmenopausal

You may not qualify if…

• Medications affecting bone resorption

Where it is running

• Purdue University — West Lafayette, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.